Hemoglobin A1c and Fructosamine for Assessing Glycemic Control in Diabetic Patients With CKD Stages 3 and 4

American Journal of Kidney Diseases

Volumn 55, Issue 5, 2010, Pages 867-874

  Chen, Harn Shen ^a,b   Wu, Tzu En ^b   Lin, Hong Da ^a,b   Jap, Tjin Shing ^a,b   Hsiao, Li Chuan ^a   Lee, Shen Hung ^a   Lin, Shu Hsia ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

chronic kidney disease; diabetes; fructosamine; Hemoglobin A1c

Indexed keywords

FRUCTOSAMINE; HEMOGLOBIN A1C; INSULIN;

ACCURACY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD GLUCOSE MONITORING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC TEST; DRUG DOSE INCREASE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PILOT PROJECTS; REFERENCE VALUES; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 77951626611     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.10.064     Document Type: Article

References (25)

1. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States (2008), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. http://www.usrds.org/adr_2008.htm Accessed June 11, 2009
2. Kramer H.J., Nguyen Q.D., Curhan G., and Hsu C.Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289 24 (2003) 3273-3277
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329 14 (1993) 977-986
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 9131 (1998) 837-853
5. Rossing K., Christensen P.K., Hovind P., Tarnow L., Rossing P., and Parving H.H. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 66 4 (2004) 1596-1605
6. Hovind P., Rossing P., Tarnow L., Smidt U.M., and Parving H.H. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 60 1 (2001) 277-283
7. Menon V., Greene T., Pereira A.A., et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol. 16 11 (2005) 3411-3417
8. American Diabetes Association. Tests of glycemia in diabetes (position statement). Diabetes Care 23 suppl 1 (2000) S80-S82
9. Goldstein D.E., Little R.R., Lorenz R.A., et al. Tests of glycemia in diabetes. Diabetes Care 27 7 (2004) 1761-1773
10. The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 10 1 (1987) 1-19
11. Rohlfing C.L., Wiedmeyer H.M., Little R.R., England J.D., Tennill A., and Goldstein D.E. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 25 2 (2002) 275-278
12. Nathan D.M., Kuenen J., Borg R., Zheng H., Schoenfeld D., and Heine R.J.A.1c.-D.A.G.S.Group. Translating the A1c assay into estimated average glucose values. Diabetes Care 31 8 (2008) 1473-1478
13. Eschbach Jr. J.W., Funk D., Adamson J., Kuhn I., Scribner B.H., and Finch C.A. Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med. 276 12 (1967) 653-658
14. Flückiger R., Harmon W., Meier W., Loo S., and Gabbay K.H. Hemoglobin carbamylation in uremia. N Engl J Med. 304 14 (1981) 823-827
15. Panzer S., Kronik G., Lechner K., Bettelheim P., Neumann E., and Dudczak R. Glycated hemoglobins (Ghb): an index of red cell survival. Blood 59 6 (1982) 1348-1350
16. Ansari A., Thomas S., and Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis. 41 3 (2003) 523-531
17. Paisey R., Banks R., Holton R., et al. Glycosylated haemoglobin in uraemia. Diabet Med. 3 5 (1986) 445-448
18. Service J.F. Correlation between glycemia and glycated hemoglobin. Compr Ther. 16 1 (1990) 33-40
19. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., and Peterson C.M. Tests of glycemia in diabetes. Diabetes Care 18 6 (1995) 896-909
20. Joy M.S., Cefalu W.T., Hogan S.L., and Nachman P.H. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis. 39 2 (2002) 297-307
21. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med. 354 23 (2006) 2473-2483
22. Howey J.E., Browning M.C., and Fraser C.G. Assay of serum fructosamine that minimizes standardization and matrix problems: use to assess components of biological variation. Clin Chem. 33 2 pt 1 (1987) 269-272
23. Larsen M.L., Hørder M., and Mogensen E.F. Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med. 323 15 (1990) 1021-1025
24. Lamb E., Mainwaring-Burton R., and Dawnay A. Effect of protein concentration on the formation of glycated albumin and fructosamine. Clin Chem. 37 12 (1991) 2138-2139
25. Schleicher E.D., Olgemöller B., Wiedenmann E., and Gerbitz K.D. Specific glycation of albumin depends on its half-life. Clin Chem. 39 4 (1993) 625-628